Clinical Trials Directory

Trials / Completed

CompletedNCT04671238

Absolute Quantification in Bone Scintigraphy

Absolute Quantification in Bone Scintigraphy: Phantom Evaluation and Clinical Application in Patients Undergoing Follow-up for Vertebral Fractures.

Status
Completed
Phase
Study type
Observational
Enrollment
21 (actual)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

While absolute quantification in 18F-FDG PET (Positon Emission Tomography) is widely used in clinical routine, absolute quantification in SPECT (Single Photon Emission Computed Tomography) is under development and its clinical interest remains to be demonstrated. Recent studies carried out on bone scan recordings show the potential interest of quantification indexes such as SUV (Standard Uptake Value).

Detailed description

In oncology, bone scan studies have reported significantly higher SUV values for secondary bone lesions compared with benign osteoarticular lesions , and some have even defined an SUVmax threshold value that points to prostatic bone metastases.

Conditions

Interventions

TypeNameDescription
DEVICESPECT CTSPECT/CT scan of the spine as part of a vertebroplasty

Timeline

Start date
2020-01-01
Primary completion
2020-11-01
Completion
2021-02-01
First posted
2020-12-17
Last updated
2022-09-13

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04671238. Inclusion in this directory is not an endorsement.